Oncoinfluencers to Follow on Social Media: Dr. Naveen Pemmaraju
We are excited to feature Dr. Naveen Pemmaraju, a prominent expert in the field of hematology/oncology, as our next oncoinfluencer.
Dr. Pemmaraju regularly engages on both X/Twitter and LinkedIn, sharing valuable information related to oncology. His posts provide insights into novel therapies, clinical trials, and developments in rare and ultra-rare myeloid malignancies. Dr. Pemmaraju’s frequent updates and insightful contributions make him a must-follow for anyone interested in leukemia and hematologic oncology.
Follow Dr. Naveen Pemmaraju on X/Twitter and LinkedIn to stay updated with his latest research and insights into leukemia treatment.
About Naveen Pemmaraju
Naveen Pemmaraju is a Professor and Director of the BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN, and AML.
While staying tuned for upcoming Oncoinfluencers, check out previous profiles on our website on influential voices in the oncology community.